Skip to main content
Premium Trial:

Request an Annual Quote

Essen, OriGene Sign Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life sciences tools and services provider Essen Instruments and OriGene will co-develop and co-market ion channel genes for use in gene expression activities in mammalian cell line research, Essen said today.

OriGene, which makes genetics-related products and has a collection of human cDNA clones, will clone and engineer ion channel genes and will optimize methods for the mammalian lines.

Ann Arbor, Mich.-based Essen will use its ion channel analysis technologies, including planar assay electrophysiology and optical imaging, to select and characterize the cell lines.

Kirk Schroeder, Essen's president, said in a statement that developing ion channel gene lines with OriGene's molecular biology capabilities "creates a powerful synergy for expanding our reagent catalogue."